Corrigendum to “Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia” [Leuk. Res. (2022) 106946]
| Autor: | Klink, Andrew J., Gajra, Ajeet, Knoth, Russell L., Marshall, Landon, Hou, Ying, McBride, Ali, Copher, Ronda |
|---|---|
| Zdroj: | In Leukemia Research January 2024 136 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect